Literature DB >> 14565794

Causes and management of hyponatremia.

Biff F Palmer1, John R Gates, Malcolm Lader.   

Abstract

OBJECTIVE: To review clinical information on the incidence and causes of hyponatremia (defined as a serum sodium level <130 mEq/L), the most common electrolyte abnormality seen in general hospital patients, and to discuss the diagnosis and treatment of hyponatremia in relation to these factors. DATA SOURCES: Primary sources and review articles were identified via MEDLINE (1981-July 2003) for entries on hyponatremia. We limited the search to specific topics including incidence, risk factors, diagnosis, treatment, and clinical disorders and medications associated with hypotonic hyponatremia. STUDY SELECTION AND DATA EXTRACTION: All of the articles identified were evaluated, and relevant and representative information was included in this review. DATA SYNTHESIS: Hyponatremia can result from several disease states, injury, surgery, physical exercise, or the administration of certain drugs (e.g., antidepressants, antiepileptics) and is associated with advanced age. Drug-induced hyponatremia is often asymptomatic and usually resolves following water restriction and monitoring of medication. Symptoms of hyponatremia are primarily neurologic; the principal danger of hyponatremia relates to effects on central nervous system function due to changes in brain size.
CONCLUSIONS: Although hyponatremia can be a serious condition, appropriate measures for the management of at-risk and affected patients will lead to full recovery in most cases.

Entities:  

Mesh:

Year:  2003        PMID: 14565794     DOI: 10.1345/aph.1D105

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  30 in total

1.  Electrolytes in the aging.

Authors:  Lynn E Schlanger; James L Bailey; Jeff M Sands
Journal:  Adv Chronic Kidney Dis       Date:  2010-07       Impact factor: 3.620

2.  Hyponatremia resulting from arginine vasopressin receptor 2 gene mutation.

Authors:  David Francisco Bes; Hernán Mendilaharzu; Raymond G Fenwick; Elvira Arrizurieta
Journal:  Pediatr Nephrol       Date:  2006-11-18       Impact factor: 3.714

3.  [A 67-year-old patient with somnolence and severe hyponatraemia].

Authors:  J Seiderer; C Rust; M Menth; T Pusl; M Jung
Journal:  Internist (Berl)       Date:  2006-06       Impact factor: 0.743

4.  The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases.

Authors:  S Rinaldi; M Santoni; G Leoni; I Fiordoliva; G Marcantognini; T Meletani; G Armento; D Santini; T Newsom-Davis; M Tiberi; F Morgese; M Torniai; M Bower; Rossana Berardi
Journal:  Support Care Cancer       Date:  2018-11-08       Impact factor: 3.603

5.  Clinical management of SIADH.

Authors:  Peter Gross
Journal:  Ther Adv Endocrinol Metab       Date:  2012-04       Impact factor: 3.565

Review 6.  Diagnosis and management of hyponatremia in cancer patients.

Authors:  Jorge J Castillo; Marc Vincent; Eric Justice
Journal:  Oncologist       Date:  2012-05-22

Review 7.  Focus on neonatal and infantile onset of nephrogenic syndrome of inappropriate antidiuresis: 12 years later.

Authors:  Flaminia Bardanzellu; Maria Cristina Pintus; Valentina Masile; Vassilios Fanos; Maria Antonietta Marcialis
Journal:  Pediatr Nephrol       Date:  2018-03-15       Impact factor: 3.714

8.  Syndrome of inappropriate antidiuretic hormone secretion (SIADH) or hyponatraemia associated with valproic Acid: four case reports from the Netherlands and a case/non-case analysis of vigibase.

Authors:  Erna Beers; Eugène P van Puijenbroek; Imke H Bartelink; Carolien M J van der Linden; Paul A F Jansen
Journal:  Drug Saf       Date:  2010-01-01       Impact factor: 5.606

Review 9.  Antipsychotic-induced hyponatraemia: a systematic review of the published evidence.

Authors:  Didier Meulendijks; Cyndie K Mannesse; Paul A F Jansen; Rob J van Marum; Toine C G Egberts
Journal:  Drug Saf       Date:  2010-02-01       Impact factor: 5.606

10.  Current and future treatment options in SIADH.

Authors:  Robert Zietse; Nils van der Lubbe; Ewout J Hoorn
Journal:  NDT Plus       Date:  2009-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.